Gene ID |
Gene Name |
Sequence Strain (Species/Organism) |
VO ID |
NCBI Gene ID |
NCBI Nucleotide GI |
NCBI Protein GI |
Locus Tag |
Genbank Accession |
Protein Accession |
3D structure: PDB ID |
Other Database IDs |
Protein Name |
Molecule Role |
Vaccines Involving this Gene |
1520
|
ABCB1 |
Homo sapiens |
|
5243
|
|
42741659
|
|
AACC02000015 |
NP_000918 |
|
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
Vaximmutor |
FluMist
Fluarix
YF-Vax
|
3565
|
ACADM |
Homo sapiens |
|
34
|
|
4557231
|
|
AH002873 |
NP_000007 |
|
|
transcript variant 3 |
Protective antigen |
Fluarix
|
3596
|
ACER3 |
Homo sapiens |
|
55331
|
|
665821252
|
|
AP000752 |
NP_001287882 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
2134
|
ADA |
Homo sapiens |
|
100
|
|
47078295
|
|
ABBA01052645 |
NP_000013 |
|
|
transcript variant X1 |
Vaximmutor |
YF-Vax
2008–2009 trivalent influenza vaccine
|
3707
|
AHCYL1 |
Homo sapiens |
|
10768
|
|
336455095
|
|
AL772411 |
NP_001229602 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3802
|
AKR1C3 |
Homo sapiens |
|
8644
|
|
359806990
|
|
AB028065 |
NP_001240837 |
|
|
transcript variant 2 |
Protective antigen |
Fluarix
|
1522
|
ALCAM |
Homo sapiens |
|
214
|
|
343168770
|
|
ABBA01061728 |
NP_001230209 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
2949
|
ALDH1A1 |
Homo sapiens |
|
216
|
|
21361176
|
RP11-151D14.2 |
ABBA01033867 |
NP_000680 |
|
|
aldehyde dehydrogenase 1 family, member A1 |
Vaximmutor |
APSV Wetvax
FluMist
|
1574
|
ANPEP |
Homo sapiens |
|
290
|
|
157266300
|
|
ABBA01053024 |
NP_001141 |
|
|
alanyl (membrane) aminopeptidase |
Vaximmutor |
Fluarix
YF-Vax
|
1475
|
ANXA2 |
Homo sapiens |
|
304
|
|
|
|
ABBA01065043 |
|
|
|
annexin A2 pseudogene 2 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1151
|
APOBEC3B |
Homo sapiens |
|
9582
|
|
22907025
|
CTA-150C2.15-003 |
AL022318 |
NP_004891 |
|
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
Vaximmutor |
Mycobacterium tuberculosis sigE mutant vaccine
YF-Vax
APSV Wetvax
Fluarix
|
1473
|
APOBEC3F |
Homo sapiens |
|
200316
|
|
54873619
|
CTA-150C2.19-001 |
ABBA01055546 |
NP_001006667 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
Fluarix
|
1456
|
APOBEC3G |
Homo sapiens |
|
60489
|
|
13399304
|
MDS019 |
ABBA01055548 |
NP_068594 |
|
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
Vaximmutor |
FluMist
|
3633
|
ARF1 |
Homo sapiens |
|
375
|
|
66879660
|
|
AH001410 |
NP_001019397 |
|
|
transcript variant 3 |
Protective antigen |
Fluarix
|
3744
|
ARFIP1 |
Homo sapiens |
|
27236
|
|
71040092
|
|
AC099339 |
NP_001020764 |
|
|
transcript variant 5 |
Protective antigen |
Fluarix
|
3614
|
ARMC10 |
Homo sapiens |
|
83787
|
|
238776793
|
|
AC007683 |
NP_001154481 |
|
|
transcript variant A |
Protective antigen |
FluMist
|
3551
|
ASH1L |
Homo sapiens |
|
55870
|
|
1482178854
|
|
AL139410 |
NP_001353106 |
|
|
transcript variant X4 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
1536
|
ATF6B |
Homo sapiens |
|
1388
|
|
209954788
|
DADB-220I18.4 |
ABBA01038104 |
NP_001129625 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
2970
|
ATP6V1B2 |
Homo sapiens |
|
526
|
|
19913428
|
|
ABBA01021549 |
NP_001684 |
|
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
Vaximmutor |
FluMist
|
2971
|
ATP6V1C1 |
Homo sapiens |
|
528
|
|
4502315
|
|
ABBA01037628 |
NP_001686 |
|
|
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 |
Vaximmutor |
APSV Wetvax
FluMist
|
1587
|
BACH2 |
Homo sapiens |
|
60468
|
|
282847373
|
RP11-63K6.2 |
ABBA01040546 |
NP_001164265 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
1592
|
BAX |
Homo sapiens |
|
581
|
|
4757838
|
|
ABBA01032954 |
NP_004315 |
|
|
epsilon |
Vaximmutor |
Fluarix
|
1586
|
BCL2L1 |
Homo sapiens |
|
598
|
|
4502381
|
RP5-857M17.3 |
ABBA01019297 |
NP_001182 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
YF-Vax
|
3590
|
C14orf119 |
Homo sapiens |
|
55017
|
|
8923615
|
|
AL117258 |
NP_060394 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
Fluarix
|
3780
|
C15orf29 |
Homo sapiens |
|
79768
|
|
13376013
|
|
AC079203 |
NP_078989 |
|
|
transcript variant X4 |
Protective antigen |
FluMist
|
2178
|
C19orf10 |
Homo sapiens |
|
56005
|
|
33457348
|
|
ABBA01056051 |
NP_061980 |
|
|
chromosome 19 open reading frame 10 |
Vaximmutor |
YF-Vax
Fluarix
|
1529
|
C1QBP |
Homo sapiens |
|
708
|
|
4502491
|
|
ABBA01054814 |
NP_001203 |
|
|
complement component 1, q subcomponent binding protein |
Vaximmutor |
FluMist
YF-Vax
|
1459
|
C3AR1 |
Homo sapiens |
|
719
|
|
4757888
|
|
AB065870 |
NP_004045 |
|
|
complement component 3a receptor 1 |
Vaximmutor |
FluMist
YF-Vax
Fluarix
|
3777
|
C3orf1 |
Homo sapiens |
|
51300
|
|
59710109
|
|
AC073352 |
NP_057673 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1495
|
C5AR1 |
Homo sapiens |
|
728
|
|
4502509
|
|
ABBA01041024 |
NP_001727 |
|
|
complement component 5a receptor 1 |
Vaximmutor |
FluMist
|
3601
|
CACNA2D3 |
|
|
|
|
|
|
|
|
|
|
|
|
FluMist
|
3580
|
CALHM2 |
Homo sapiens |
|
51063
|
|
21361521
|
|
AL139339 |
NP_057000 |
|
|
transcript variant X7 |
Protective antigen |
FluMist
|
1438
|
CASP1 |
Homo sapiens |
|
834
|
|
4502573
|
|
ABBA01039912 |
NP_001214 |
|
|
epsilon |
Vaximmutor |
FluMist
Fluarix
YF-Vax
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
1550
|
CAV1 |
Homo sapiens |
|
857
|
|
290542359
|
|
AACC02000001 |
NP_001166366 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
|
3689
|
CBFA2T2 |
Homo sapiens |
|
9139
|
|
74229008
|
|
AF076449 |
NP_001028171 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3618
|
CBR4 |
Homo sapiens |
|
84869
|
|
40254992
|
|
AC021151 |
NP_116172 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3574
|
CCDC56 |
|
|
|
|
|
|
|
|
|
|
|
|
FluMist
Fluarix
|
3599
|
CCDC88A |
Homo sapiens |
|
55704
|
|
208022632
|
|
AC012358 |
NP_001129069 |
|
|
transcript variant X10 |
Protective antigen |
FluMist
|
1500
|
CCL3 |
Homo sapiens |
|
6348
|
|
4506843
|
|
ABBA01011243 |
NP_002974 |
|
|
chemokine (C-C motif) ligand 3 |
Vaximmutor |
FluMist
|
1498
|
CCL4 |
Homo sapiens |
|
6351
|
|
4506845
|
|
ABBA01011244 |
NP_002975 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
1519
|
CCND3 |
Homo sapiens |
|
896
|
|
209862835
|
RP5-973N23.3 |
ABBA01050738 |
NP_001129489 |
|
|
transcript variant 4 |
Vaximmutor |
FluMist
2008–2009 trivalent influenza vaccine
|
1523
|
CCR1 |
Homo sapiens |
|
1230
|
|
4502631
|
|
ABBA01024719 |
NP_001286 |
|
|
chemokine (C-C motif) receptor 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1482
|
CCR2 |
Homo sapiens |
|
729230
|
|
183979980
|
hCG_14621 |
ABBA01024718 |
NP_001116513 |
|
|
A |
Vaximmutor |
FluMist
APSV Wetvax
Fluarix
|
1441
|
CD14 |
Homo sapiens |
|
929
|
|
4557417
|
|
AC116353 |
NP_000582 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
2133
|
CD163 |
Homo sapiens |
|
9332
|
|
344179110
|
|
ABBA01012200 |
NP_004235 |
|
|
transcript variant 2 |
Vaximmutor |
YF-Vax
APSV Wetvax
FluMist
|
3636
|
CD1D |
Homo sapiens |
|
912
|
|
982742445
|
|
AF142668 |
NP_001306074 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3010
|
CD2 |
Homo sapiens |
|
914
|
|
156071472
|
RP4-655N15.2 |
ABBA01068494 |
NP_001758 |
|
|
transcript variant X1 |
Vaximmutor |
APSV Wetvax
FluMist
|
1461
|
CD244 |
Homo sapiens |
|
51744
|
|
262263435
|
|
ABBA01016608 |
NP_001160135 |
|
|
transcript variant 3 |
Vaximmutor |
FluMist
YF-Vax
|
1792
|
CD27 |
Homo sapiens |
|
939
|
|
4507587
|
|
AC005840 |
NP_001233 |
|
|
transcript variant X1 |
Protective antigen |
YF-Vax
FluMist
Fluarix
|
1570
|
CD28 |
Homo sapiens |
|
940
|
|
340545508
|
|
ABBA01062617 |
NP_001230006 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
YF-Vax
|
3637
|
CD33 |
Homo sapiens |
|
945
|
|
130980072
|
|
AC063977 |
NP_001076087 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
1585
|
CD36 |
Homo sapiens |
|
948
|
|
48375178
|
|
AACC02000015 |
NP_000063 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
YF-Vax
APSV Wetvax
FluMist
|
1544
|
CD38 |
Homo sapiens |
|
952
|
|
38454326
|
|
ABBA01032572 |
NP_001766 |
|
|
CD38 molecule |
Vaximmutor |
Fluarix
YF-Vax
|
1788
|
CD38 |
Homo sapiens |
|
952
|
|
38454326
|
|
AC005798 |
NP_001766 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
1571
|
CD4 |
Homo sapiens |
|
920
|
|
10835167
|
|
ABBA01017655 |
NP_000607 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
|
1494
|
CD55 |
Homo sapiens |
|
1604
|
|
10835143
|
RP11-357P18.1 |
AB003312 |
NP_000565 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
APSV Wetvax
|
1483
|
CD86 |
Homo sapiens |
|
942
|
|
332634950
|
|
ABBA01016472 |
NP_001193853 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
|
3685
|
CDC14A |
Homo sapiens |
|
8556
|
|
984655777
|
|
AC104457 |
NP_001306139 |
|
|
transcript variant X5 |
Protective antigen |
FluMist
|
1957
|
CDKN1C |
Homo sapiens |
|
1028
|
|
4557441
|
|
ABBA01032079 |
NP_000067 |
|
|
transcript variant X2 |
Vaximmutor |
YF-Vax
Fluarix
|
2734
|
CHST15 |
Homo sapiens |
|
51363
|
|
398303854
|
RP11-47G11.1 |
AB025341 |
NP_001257693 |
|
|
transcript variant X4 |
Vaximmutor |
YF-Vax
FluMist
|
1440
|
CIITA |
Homo sapiens |
|
4261
|
|
156938336
|
|
ABBA01006803 |
NP_000237 |
|
|
class II, major histocompatibility complex, transactivator |
Vaximmutor |
FluMist
|
1924
|
CLEC 12A |
Homo sapiens |
|
160364
|
|
333609225
|
|
ABBA01067795 |
NP_001193939 |
|
|
transcript variant 3 |
Vaximmutor |
YF-Vax
FluMist
|
2102
|
CNDP2 |
Homo sapiens |
|
55748
|
|
271398277
|
|
ABBA01056327 |
NP_001161971 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
FluMist
|
3692
|
COPB2 |
Homo sapiens |
|
9276
|
|
4758032
|
|
AC024933 |
NP_004757 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3804
|
COPB2 |
Homo sapiens |
|
9276
|
|
4758032
|
|
AC024933 |
NP_004757 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3609
|
CREBZF |
Homo sapiens |
|
58487
|
|
88900495
|
|
AP000642 |
NP_001034707 |
|
|
transcript variant 5 |
Protective antigen |
FluMist
|
1515
|
CRK |
Homo sapiens |
|
1398
|
|
41327710
|
|
ABBA01054662 |
NP_005197 |
|
|
I |
Vaximmutor |
FluMist
|
3588
|
CRLS1 |
Homo sapiens |
|
54675
|
|
188536108
|
|
AL035461 |
NP_001120930 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3701
|
CRYZL1 |
Homo sapiens |
|
9946
|
|
90669511
|
|
AP000304 |
NP_665857 |
|
|
crystallin zeta like 1 |
Protective antigen |
FluMist
|
1457
|
CSF1R from humans |
Homo sapiens |
|
1436
|
|
27262659
|
|
ABBA01026285 |
NP_005202 |
|
|
colony stimulating factor 1 receptor |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1481
|
CSF2RA |
Homo sapiens |
|
1438
|
|
238908515
|
|
ABBA01055739 |
NP_001155001 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
1503
|
CSF3 |
Homo sapiens |
|
1440
|
|
4503079
|
|
ABBA01031851 |
NP_000750 |
|
|
transcript variant 5 |
Vaximmutor |
FluMist
|
2690
|
CTBP2 |
Homo sapiens |
|
1488
|
|
145580578
|
RP11-59C5.2 |
ABBA01034161 |
NP_001077383 |
|
|
transcript variant 3 |
Vaximmutor |
YF-Vax
FluMist
Fluarix
|
3785
|
CTSC |
Homo sapiens |
|
1075
|
|
167000671
|
|
AC011088 |
NP_001107645 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
1484
|
CX3CR1 |
Homo sapiens |
|
1524
|
|
283837924
|
|
ABBA01024808 |
NP_001164642 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
Fluarix
|
1470
|
CXCL1 |
Homo sapiens |
|
2919
|
|
4504153
|
|
ABBA01022993 |
NP_001502 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
YF-Vax
|
3556
|
CXCR3 |
Homo sapiens |
|
2833
|
|
218563730
|
|
AB032735 |
NP_001136269 |
|
|
transcript variant X4 |
Protective antigen |
2011–2012 trivalent inactivated vaccine (A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008).
|
3774
|
CYAT1 |
Homo sapiens |
|
100290481
|
|
|
|
|
|
|
|
immunoglobulin lambda light chain-like |
Protective antigen |
Fluarix
|
2038
|
CYBB |
Homo sapiens |
|
1536
|
|
6996021
|
|
AB013904 |
NP_000388 |
|
|
cytochrome b-245, beta polypeptide |
Vaximmutor |
YF-Vax
APSV Wetvax
FluMist
|
3059
|
CYFIP1 |
Homo sapiens |
|
23191
|
|
74271907
|
|
ABBA01040251 |
NP_001028200 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
FluMist
|
3547
|
CYLD |
Homo sapiens |
|
1540
|
|
109637774
|
|
AC007728 |
NP_001035814 |
|
|
transcript variant X6 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
1477
|
DAPK1 |
Homo sapiens |
|
1612
|
|
89363047
|
|
ABBA01016326 |
NP_004929 |
|
|
death-associated protein kinase 1 |
Vaximmutor |
FluMist
|
3704
|
DCAF7 |
Homo sapiens |
|
10238
|
|
108936958
|
|
AC046185 |
NP_005819 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3595
|
DDX19A |
Homo sapiens |
|
55308
|
|
1001624449
|
|
AC012184 |
NP_001307451 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3541
|
DDX21 |
Homo sapiens |
|
9188
|
|
379317177
|
|
AH009497 |
NP_001243839 |
|
|
transcript variant 1 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3543
|
DDX41 |
Homo sapiens |
|
51428
|
|
1012431804
|
|
AC145098 |
NP_001308661 |
|
|
transcript variant 1 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
1577
|
DDX58 from humans |
|
|
23586
|
|
|
|
|
|
|
|
|
Vaximmutor |
Fluarix
YF-Vax
|
1940
|
DDX60 |
Homo sapiens |
|
55601
|
|
222831595
|
|
ABBA01070327 |
NP_060101 |
|
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
Vaximmutor |
YF-Vax
FluMist
|
3611
|
DENND2D |
Homo sapiens |
|
79961
|
|
426214085
|
|
AL355816 |
NP_001258762 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
1594
|
DNAJC10 |
Homo sapiens |
|
54431
|
|
409971397
|
UNQ495/PRO1012 |
ABBA01062301 |
NP_001258510 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
|
3623
|
DNAJC24 |
Homo sapiens |
|
120526
|
|
89111951
|
|
AC108456 |
NP_859057 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3077
|
DPYD |
|
|
|
|
|
|
|
|
|
|
|
|
APSV Wetvax
FluMist
|
2145
|
DPYSL2 |
Homo sapiens |
|
1808
|
|
308818195
|
|
AB020777 |
NP_001184222 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
FluMist
|
3640
|
DYNC1I2 |
Homo sapiens |
|
1781
|
|
422398885
|
|
AC064826 |
NP_001258714 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3539
|
E2F2 |
Homo sapiens |
|
1870
|
|
4758226
|
|
AF518877 |
NP_004082 |
|
|
transcript variant X2 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3602
|
EAF2 |
Homo sapiens |
|
55840
|
|
987996497
|
|
AC072031 |
NP_001306970 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
Fluarix
|
3603
|
ECHDC1 |
Homo sapiens |
|
55862
|
|
157694516
|
|
AL109939 |
NP_001002030 |
|
|
transcript variant X4 |
Protective antigen |
FluMist
Fluarix
|
3612
|
EDEM3 |
Homo sapiens |
|
80267
|
|
985801665
|
|
AL096819 |
NP_001306889 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3683
|
EEA1 |
Homo sapiens |
|
8411
|
|
55770888
|
|
AC016136 |
NP_003557 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
1468
|
EIF2S1 |
Homo sapiens |
|
1965
|
|
4758256
|
|
ABBA01023713 |
NP_004085 |
|
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
Vaximmutor |
FluMist
Fluarix
APSV Wetvax
|
3643
|
ELAVL1 |
Homo sapiens |
|
1994
|
|
38201714
|
|
AC008975 |
NP_001410 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3592
|
ELP3 |
Homo sapiens |
|
55140
|
|
545746389
|
|
AC019031 |
NP_001271149 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3681
|
EOMES |
Homo sapiens |
|
8320
|
|
499591691
|
|
AC098614 |
NP_001265111 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3544
|
ERCC1 |
Homo sapiens |
|
2067
|
|
260593725
|
|
AC092309 |
NP_001159521 |
|
|
transcript variant 3 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3745
|
ERLEC1 |
Homo sapiens |
|
27248
|
|
188528696
|
|
AC007883 |
NP_001120869 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
3597
|
ETNK1 |
Homo sapiens |
|
55500
|
|
87298843
|
|
AC087241 |
NP_001034570 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
1510
|
ETS2 |
Homo sapiens |
|
2114
|
|
372466582
|
|
ABBA01011089 |
NP_001243224 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
3586
|
EVL |
Homo sapiens |
|
51466
|
|
1057503129
|
|
AL133368 |
NP_001317150 |
|
|
transcript variant X6 |
Protective antigen |
FluMist
|
3545
|
EXOSC3 |
Homo sapiens |
|
51010
|
|
50511939
|
|
AL138752 |
NP_001002269 |
|
|
transcript variant 2 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3582
|
FAM198B |
Homo sapiens |
|
51313
|
|
190358490
|
|
AC098679 |
NP_001026870 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
2031
|
FAM26F |
Homo sapiens |
|
441168
|
|
62988336
|
RP1-93H18.5 |
ABBA01026046 |
NP_001010919 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
Fluarix
|
3548
|
FCER1G |
Homo sapiens |
|
2207
|
|
4758344
|
|
AC243898 |
NP_004097 |
|
|
Fc fragment of IgE receptor Ig |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3644
|
FCGR1B |
Homo sapiens |
|
2210
|
|
219804014
|
|
AC244453 |
NP_001004340 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3727
|
FGD2 |
Homo sapiens |
|
221472
|
|
189217917
|
|
AL160264 |
NP_775829 |
|
|
transcript variant X5 |
Protective antigen |
FluMist
|
3624
|
FGD4 |
Homo sapiens |
|
121512
|
|
751247051
|
|
AC084824 |
NP_001291409 |
|
|
transcript variant X14 |
Protective antigen |
FluMist
|
3112
|
FGL2 |
Homo sapiens |
|
10875
|
|
5730075
|
|
ABBA01058001 |
NP_006673 |
|
|
fibrinogen-like 2 |
Vaximmutor |
APSV Wetvax
FluMist
|
2198
|
FKBP11 |
Homo sapiens |
|
51303
|
|
219842217
|
UNQ336/PRO535 |
ABBA01031494 |
NP_001137253 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
Fluarix
|
3718
|
FKBP15 |
Homo sapiens |
|
23307
|
|
150010552
|
|
AL449105 |
NP_056073 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3645
|
FKBP5 |
Homo sapiens |
|
2289
|
|
224809327
|
|
AL033519 |
NP_001139247 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
1478
|
FLT3 |
Homo sapiens |
|
2322
|
|
121114304
|
RP11-153M24.3 |
ABBA01035730 |
NP_004110 |
|
|
fms-related tyrosine kinase 3 |
Vaximmutor |
FluMist
|
1512
|
FOS |
Homo sapiens |
|
2353
|
|
4885241
|
|
AB022275 |
NP_005243 |
|
|
FBJ murine osteosarcoma viral oncogene homolog |
Vaximmutor |
FluMist
|
3646
|
FYN |
Homo sapiens |
|
2534
|
|
4503823
|
|
AL109916 |
NP_002028 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3702
|
G3BP1 |
Homo sapiens |
|
10146
|
|
5031703
|
|
AC091982 |
NP_005745 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3563
|
GAPT |
|
|
|
|
|
|
|
|
|
|
|
|
Fluarix
|
3725
|
GAPT |
Homo sapiens |
|
202309
|
|
750321555
|
|
AC008814 |
NP_001291357 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
Fluarix
|
3803
|
GGH |
Homo sapiens |
|
8836
|
|
4503987
|
|
AC120042 |
NP_003869 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3695
|
GGPS1 |
Homo sapiens |
|
9453
|
|
83700220
|
|
AL391994 |
NP_001032354 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3724
|
GIMAP1 |
Homo sapiens |
|
170575
|
|
18594498
|
|
AACC02000108 |
NP_570115 |
|
|
GTPase, IMAP family member 1 |
Protective antigen |
FluMist
|
3594
|
GIMAP4 |
Homo sapiens |
|
55303
|
|
1391723601
|
|
AACC02000108 |
NP_001350461 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
Fluarix
|
3735
|
GIMAP6 |
Homo sapiens |
|
474344
|
|
346421479
|
|
AACC02000108 |
NP_001231000 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
2104
|
GIMAP8 |
Homo sapiens |
|
155038
|
|
28416956
|
|
AACC02000108 |
NP_783161 |
|
|
transcript variant X2 |
Vaximmutor |
YF-Vax
FluMist
Fluarix
|
1564
|
GOPC |
Homo sapiens |
|
57120
|
|
62868213
|
|
ABBA01026037 |
NP_001017408 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
1969
|
GPBAR1 |
Homo sapiens |
|
151306
|
|
116284384
|
|
AB083601 |
NP_001070659 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
FluMist
Fluarix
|
3578
|
GPR171 |
Homo sapiens |
|
29909
|
|
153792776
|
|
AC078816 |
NP_037440 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3648
|
GTF2H1 |
Homo sapiens |
|
2965
|
|
214831601
|
|
AC084117 |
NP_001135779 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
Fluarix
|
3736
|
GUSBP3 |
Homo sapiens |
|
653188
|
|
|
|
AC118459 |
|
|
|
glucuronidase, beta pseudogene 3 |
Vaximmutor |
FluMist
|
3149
|
HCK |
Homo sapiens |
|
3055
|
|
287326139
|
RP5-836N17.3 |
ABBA01019283 |
NP_001165600 |
|
|
transcript variant 3 |
Vaximmutor |
APSV Wetvax
FluMist
|
3587
|
HECA |
Homo sapiens |
|
51696
|
|
7706435
|
|
AB033496 |
NP_057301 |
|
|
hdc homolog, cell cycle regulator |
Protective antigen |
FluMist
|
3572
|
HERC4 |
Homo sapiens |
|
26091
|
|
499137509
|
|
AC024258 |
NP_001265114 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3649
|
HIST1H1D |
Homo sapiens |
|
3007
|
|
4885377
|
|
AF531303 |
NP_005311 |
|
|
histone cluster 1 H1 family member d |
Protective antigen |
FluMist
|
3682
|
HIST1H2BG |
Homo sapiens |
|
8339
|
|
4504257
|
|
AF531290 |
NP_003509 |
|
|
histone cluster 1 H2B family member g |
Protective antigen |
FluMist
|
3650
|
HNMT |
Homo sapiens |
|
3176
|
|
66932963
|
|
AB041388 |
NP_001019245 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
2548
|
HNRNPU |
Homo sapiens |
|
3192
|
|
14141161
|
RP11-11N7.3 |
ABBA01047188 |
NP_004492 |
|
|
transcript variant 2 |
Vaximmutor |
2008–2009 trivalent influenza vaccine
|
3170
|
HSD17B4 |
Homo sapiens |
|
3295
|
|
4504505
|
|
ABBA01068976 |
NP_000405 |
|
|
transcript variant 2 |
Vaximmutor |
APSV Wetvax
FluMist
|
1538
|
HSP90B1 |
Homo sapiens |
|
7184
|
|
4507677
|
|
ABBA01053210 |
NP_003290 |
|
|
heat shock protein 90kDa beta (Grp94), member 1 |
Vaximmutor |
Fluarix
YF-Vax
|
1499
|
HSPA1A |
Homo sapiens |
|
3303
|
|
194248072
|
DAQB-147D11.1 |
AB018045 |
NP_005336 |
|
|
heat shock 70kDa protein 1A |
Vaximmutor |
FluMist
|
1530
|
HSPD1 |
Homo sapiens |
|
3329
|
|
31542947
|
|
ABBA01062482 |
NP_002147 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
|
1427
|
Human CAMK4 (CaMKIV) |
Homo sapiens |
|
814
|
|
4502557
|
|
AC010275 |
NP_001735 |
|
|
calcium/calmodulin-dependent protein kinase IV |
Vaccine protection marker |
FluMist
|
1435
|
human STAT1 |
Homo sapiens |
|
6772
|
|
6274552
|
|
ABBA01062392 |
NP_009330 |
|
|
alpha |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1561
|
HYOU1 |
Homo sapiens |
|
10525
|
|
195976805
|
|
AB009979 |
NP_001124463 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
1466
|
ICAM1 |
Homo sapiens |
|
3383
|
|
167466198
|
|
ABBA01029939 |
NP_000192 |
|
|
intercellular adhesion molecule 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
1464
|
ICAM2 |
Homo sapiens |
|
3384
|
|
153082696
|
|
ABBA01035312 |
NP_000864 |
|
|
transcript variant 4 |
Vaximmutor |
FluMist
APSV Wetvax
|
3651
|
IDH1 |
Homo sapiens |
|
3417
|
|
538917488
|
|
AC016697 |
NP_001269315 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
Fluarix
|
1458
|
IFI16 |
Homo sapiens |
|
3428
|
|
330864753
|
|
ABBA01016621 |
NP_001193496 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
YF-Vax
|
1573
|
IFI30 |
Homo sapiens |
|
10437
|
|
29150261
|
|
ABBA01051249 |
NP_006323 |
|
|
interferon, gamma-inducible protein 30 |
Vaximmutor |
Fluarix
YF-Vax
APSV Wetvax
|
1439
|
IFI35 |
Homo sapiens |
|
3430
|
|
1057503245
|
|
AC055866 |
NP_001317159 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
YF-Vax
APSV Wetvax
|
3653
|
IFI35 |
Homo sapiens |
|
3430
|
|
1057503245
|
|
AC055866 |
NP_001317159 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3561
|
Ifi47 |
Mus musculus |
|
15953
|
|
410991938
|
|
AL645688 |
NP_001258605 |
|
|
transcript variant 3 |
Protective antigen |
RE
|
1511
|
IFNAR1 |
Homo sapiens |
|
3454
|
|
46488932
|
|
ABBA01057338 |
NP_000620 |
|
|
interferon (alpha, beta and omega) receptor 1 |
Vaximmutor |
FluMist
Fluarix
|
1428
|
IFNG from Macaca nemestrina |
|
|
|
|
|
|
|
|
|
|
|
|
HIV DNA vaccine pHIS-SHIV-B
C-KCE (vBAC-C-KCE)
|
1490
|
IFNGR1 |
Homo sapiens |
|
3459
|
|
4557880
|
RP3-503F13.3 |
ABBA01025818 |
NP_000407 |
|
|
interferon gamma receptor 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
1566
|
IFNGR2 |
Homo sapiens |
|
3460
|
|
47419934
|
|
ABBA01057340 |
NP_005525 |
|
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
Vaximmutor |
Fluarix
APSV Wetvax
|
1497
|
IFRD1 |
Homo sapiens |
|
3475
|
|
55953131
|
|
AACC02000001 |
NP_001007246 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
|
1160
|
IgA |
Mus musculus |
|
238447
|
|
|
|
AC160982 |
|
|
|
immunoglobulin heavy constant alpha |
Vaximmutor |
Streptococcus equi vicK mutant vaccine
Bordetella bronchiseptica aroA mutant vaccine (strain BBS18)
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
Salmonella Typhimurium clpP mutant vaccine
Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine
Salmonella Typhimurium hfq mutant vaccine
Salmonella Typhimurium poxA mutant vaccine
Influenza virus CTA1-3M2e-DD protein vaccine
S. pneumoniae RASV synthesizing PsaA
S. pyogenes FBP54 Protein Vaccine
S. pyogenes SfbI Protein Vaccine
C. jejuni DNA vaccine pcDNA3.1(+)-cadF
C. jejuni DNA vaccine pcDNA3.1(+)-peblA
C. jejuni FspA1 protein vaccine
C. jejuni MBP-FlaA protein vaccine
C. muridarum MOMP protein vaccine
C. pneumoniae LcrE protein vaccine
BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1))
M2 mutant from Influenza A
S. equi Subunit EAG, FNZ and SFS Protein Vaccine
HIV DNA vaccine env-pcDNA3.1 encoding env
|
1161
|
IgG |
Mus musculus |
|
16059
|
|
|
|
AF010213 |
|
|
|
immunoglobulin heavy chain (V7183 family) |
Vaximmutor |
Streptococcus equi vicK mutant vaccine
Bordetella bronchiseptica aroA mutant vaccine (strain BBS18)
Bordetella pertussis aroA mutant vaccine
B. melitensis WR201 (16MΔpurEK)
Francisella tularensis capB mutant vaccine
Yersinia enterocolitica sodA mutant vaccine
Yersinia pestis guaBA mutant vaccine
Yersinia pestis smpB/ssrA mutant vaccine
Salmonella enterica fliC/guaB mutant vaccine
Salmonella Typhimurium guaBA/clpP mutant vaccine
Salmonella Typhi phoP mutant vaccine
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
Salmonella Typhimurium clpP mutant vaccine
Salmonella Enteritidis guaBA/clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
Salmonella Typhimurium hfq mutant vaccine
Salmonella Typhimurium poxA mutant vaccine
Salmonella Typhimurium ruvB mutant vaccine
Herpes simplex virus 2 ICP0 mutant vaccine
West Nile virus C protein mutant vaccine
Leishmania donovani cen1 mutant vaccine
Tetanus Toxoid with Calcium Phosphate
Tetanus Toxoid with Stearyl Tyrosine
S. agalactiae Rib Protein Vaccine
S. pneumoniae RASV synthesizing PsaA
S. pyogenes FbaA Protein Vaccine
S. pyogenes FBP54 Protein Vaccine
S. pyogenes SfbI Protein Vaccine
S. pyogenes Sib35 Protein Vaccine
C. jejuni DNA vaccine pcDNA3.1(+)-cadF
C. jejuni DNA vaccine pcDNA3.1(+)-peblA
C. jejuni FspA1 protein vaccine
C. jejuni MBP-FlaA protein vaccine
C. muridarum MOMP protein vaccine
BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1))
M2 mutant from Influenza A
HIV DNA vaccine gp120
|
1194
|
IgGa |
Equus caballus |
|
|
|
|
|
|
|
|
|
|
Vaximmutor |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/equine/Kentucky/1/1981(H3N8))
Influenza virus DNA vaccine encoding HA of Equine influenza virus H3N8
|
1195
|
IgGb |
Equus caballus |
|
|
|
|
|
|
|
|
|
|
Vaximmutor |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/equine/Kentucky/1/1981(H3N8))
Influenza virus DNA vaccine encoding HA of Equine influenza virus H3N8
|
1584
|
IGH@ |
|
|
|
|
|
|
|
|
|
|
|
|
Fluarix
|
1542
|
IGHA1 |
Homo sapiens |
|
3493
|
|
|
|
ABBA01074082 |
|
|
|
immunoglobulin heavy constant alpha 1 |
Vaximmutor |
Fluarix
|
1583
|
IGHD |
Homo sapiens |
|
3495
|
|
|
|
ABBA01074084 |
|
|
|
immunoglobulin heavy constant delta |
Vaximmutor |
Fluarix
|
1107
|
Ighg1 |
Mus musculus |
|
16017
|
|
|
|
AC160982 |
|
|
|
|
Vaximmutor |
B. abortus subunit vaccine using L7/L12
Brucella abortus S19 vjbR mutant vaccine
KKF24
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
Salmonella Typhimurium IppA/IppB/msbB
Salmonella Typhimurium IppB/msbB mutant vaccine
Influenza virus CTA1-3M2e-DD protein vaccine
Leishmania donovani cen1 mutant vaccine
pSecTag-PA83
Dobrava-Belgrade virus S nucleocapsid protein vaccine
PCV2 DNA Vaccine encoding ORF2 Protein
C. parvum DNA vaccine encoding CP23
B. abortus DNA vaccine encoding RplL and Omp16
HIV DNA vaccine APL 400–003 encoding env and rev
HIV DNA vaccine aroC+Gag encoding gag
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
|
3183
|
IGHG1 |
Homo sapiens |
|
3500
|
|
|
|
ABBA01074082 |
|
|
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
Vaximmutor |
APSV Wetvax
Fluarix
|
1541
|
IGHM |
Homo sapiens |
|
3507
|
|
|
|
AB035268 |
|
|
|
immunoglobulin heavy constant mu |
Vaximmutor |
Fluarix
|
1106
|
Ighv1-9 |
Mus musculus |
|
668478
|
|
|
|
AC073561 |
|
|
|
immunoglobulin heavy variable V1-9 |
Vaximmutor |
B. abortus subunit vaccine using L7/L12
Brucella abortus S19 vjbR mutant vaccine
Francisella tularensis capB mutant vaccine
Francisella tularensis wbtA mutant vaccine
KKF24
Salmonella Typhi phoP mutant vaccine
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
Herpes simplex virus type 1 DNA vaccine encoding GE
Influenza virus CTA1-3M2e-DD protein vaccine
Leishmania donovani cen1 mutant vaccine
Leishmania infantum HSP70 II mutant vaccine
C. abortus DNA vaccine encoding DnaK
C. abortus DNA vaccine encoding MOMP
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/Hong Kong/1/68(H3N2))
PCV2 DNA Vaccine encoding ORF2 Protein
C. parvum DNA vaccine encoding CP23
B. abortus DNA vaccine encoding RplL and Omp16
HIV DNA vaccine APL 400–003 encoding env and rev
HIV DNA vaccine aroC+Gag encoding gag
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
|
1821
|
IGJ |
Homo sapiens |
|
3512
|
|
21489959
|
|
AC009570 |
NP_653247 |
|
|
joining chain of multimeric IgA and IgM |
Protective antigen |
YF-Vax
Fluarix
|
1546
|
IGKC |
Homo sapiens |
|
3514
|
|
|
|
AC096579 |
|
|
|
immunoglobulin kappa constant |
Vaximmutor |
Fluarix
APSV Wetvax
|
3748
|
IGKV3-20 |
Homo sapiens |
|
28912
|
|
|
|
AC116654 |
|
|
|
immunoglobulin kappa variable 3-20 |
Protective antigen |
Fluarix
|
1548
|
IGL@ |
Homo sapiens |
|
3535
|
|
|
|
ABBA01055078 |
|
|
|
immunoglobulin lambda locus |
Vaximmutor |
Fluarix
|
3789
|
IGLL1 |
Homo sapiens |
|
3543
|
|
13399298
|
|
AH001489 |
NP_064455 |
|
|
transcript variant 2 |
Protective antigen |
Fluarix
|
2596
|
IGLV1-44 |
Homo sapiens |
|
28823
|
|
|
|
ABBA01055083 |
|
|
|
immunoglobulin lambda variable 1-44 |
Vaximmutor |
YF-Vax
Fluarix
|
3747
|
IGLV2-23 |
Homo sapiens |
|
28813
|
|
|
|
AC244250 |
|
|
|
immunoglobulin lambda variable 2-23 |
Protective antigen |
Fluarix
|
3746
|
IGLV3-19 |
Homo sapiens |
|
28797
|
|
|
|
AC244250 |
|
|
|
immunoglobulin lambda variable 3-19 |
Protective antigen |
Fluarix
|
1480
|
IKBKB |
Homo sapiens |
|
3551
|
|
299758411
|
|
ABBA01021152 |
NP_001177649 |
|
|
transcript variant 5 |
Vaximmutor |
FluMist
|
1589
|
IKZF1 |
Homo sapiens |
|
10320
|
|
334085209
|
tcag7.1178 |
AACC02000075 |
NP_001207694 |
|
|
transcript variant 3 |
Vaximmutor |
FluMist
|
1485
|
IL10RB |
Homo sapiens |
|
3588
|
|
24430215
|
|
ABBA01057336 |
NP_000619 |
|
|
interleukin 10 receptor, beta |
Vaximmutor |
FluMist
Fluarix
|
1521
|
IL13RA1 |
Homo sapiens |
|
3597
|
|
4504647
|
RP13-128O4.2 |
AB031393 |
NP_001551 |
|
|
interleukin 13 receptor, alpha 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
1516
|
IL18R1 |
Homo sapiens |
|
8809
|
|
4504655
|
|
ABBA01073899 |
NP_003846 |
|
|
interleukin 18 receptor 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
1189
|
IL1B |
Homo sapiens |
|
3553
|
|
10835145
|
|
AC079753 |
NP_000567 |
|
|
interleukin 1, beta |
Vaximmutor |
VP1 DNA Vaccine
FluMist
|
1116
|
IL2 |
Homo sapiens |
|
3558
|
|
28178861
|
|
AC022489 |
NP_000577 |
|
|
interleukin 2 |
Vaximmutor |
Bacille Calmette-Guérin (BCG)
2008–2009 trivalent influenza vaccine
|
1588
|
IL21R |
Homo sapiens |
|
50615
|
|
11141869
|
UNQ3121/PRO10273 |
ABBA01017156 |
NP_068570 |
|
|
transcript variant 3 |
Vaximmutor |
Fluarix
|
1525
|
IL4R |
Homo sapiens |
|
3566
|
|
4557669
|
582J2.1 |
ABBA01017154 |
NP_000409 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
1118
|
IL6 |
Homo sapiens |
|
3569
|
|
10834984
|
|
AC073072 |
NP_000591 |
|
|
interleukin 6 (interferon, beta 2) |
|
Bacille Calmette-Guérin (BCG)
FluMist
2008–2009 trivalent influenza vaccine
|
1463
|
IL6R |
Homo sapiens |
|
3570
|
|
4504673
|
|
ABBA01049484 |
NP_000556 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
Fluarix
|
1502
|
IL6ST |
Homo sapiens |
|
3572
|
|
300244535
|
|
ABBA01015755 |
NP_001177910 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
Fluarix
|
1773
|
IL7R |
Homo sapiens |
|
3575
|
|
28610151
|
|
AC112204 |
NP_002176 |
|
|
transcript variant 1 |
Protective antigen |
YF-Vax
APSV Wetvax
FluMist
|
1471
|
IL8 |
Homo sapiens |
|
3576
|
|
10834978
|
|
ABBA01022993 |
NP_000575 |
|
|
interleukin 8 |
Vaximmutor |
FluMist
Recombinant Aeromonas hydrophila vaccine (Aera)
|
1504
|
IRAK1 |
Homo sapiens |
|
3654
|
|
68800343
|
|
ABBA01045321 |
NP_001020413 |
|
|
transcript variant 3 |
Vaximmutor |
FluMist
|
1465
|
IRAK3 |
Homo sapiens |
|
11213
|
|
216547504
|
|
ABBA01026575 |
NP_001135995 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
1533
|
IRF2 |
Homo sapiens |
|
3660
|
|
153082752
|
|
ABBA01070515 |
NP_002190 |
|
|
interferon regulatory factor 2 |
Vaximmutor |
FluMist
Fluarix
APSV Wetvax
|
1444
|
IRF5 |
Homo sapiens |
|
3663
|
|
291190719
|
|
AACC02000035 |
NP_001092097 |
|
|
transcript variant 5 |
Vaximmutor |
FluMist
|
1474
|
IRF7 |
Homo sapiens |
|
3665
|
|
4758610
|
|
ABBA01015197 |
NP_001563 |
|
|
b |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1524
|
ISG20 |
Homo sapiens |
|
3669
|
|
6857800
|
|
ABBA01053000 |
NP_002192 |
|
|
interferon stimulated exonuclease gene 20kDa |
Vaximmutor |
FluMist
YF-Vax
|
1528
|
ITGA4 |
Homo sapiens |
|
3676
|
|
67191027
|
|
ABBA01062287 |
NP_000876 |
|
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
Vaximmutor |
FluMist
Fluarix
|
2207
|
ITM2C |
Homo sapiens |
|
81618
|
|
60302912
|
hucep-14 |
ABBA01050110 |
NP_001012532 |
|
|
transcript variant 5 |
Vaximmutor |
YF-Vax
Fluarix
|
1513
|
IVNS1ABP |
Homo sapiens |
|
10625
|
|
24475847
|
RP4-635A23.5 |
ABBA01027719 |
NP_006460 |
|
|
influenza virus NS1A binding protein |
Vaximmutor |
FluMist
|
1534
|
JAK2 |
Homo sapiens |
|
3717
|
|
4826776
|
|
ABBA01065417 |
NP_004963 |
|
|
Janus kinase 2 |
Vaximmutor |
FluMist
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
1462
|
JUN |
Homo sapiens |
|
3725
|
|
4758616
|
|
ABBA01074656 |
NP_002219 |
|
|
jun proto-oncogene |
Vaximmutor |
FluMist
|
3203
|
KCNE3 |
Homo sapiens |
|
10008
|
|
4885443
|
|
ABBA01017487 |
NP_005463 |
|
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3 |
Vaximmutor |
APSV Wetvax
FluMist
Fluarix
|
3622
|
KCTD12 |
Homo sapiens |
|
115207
|
|
19923973
|
|
AC000403 |
NP_612453 |
|
|
potassium channel tetramerization domain containing 12 |
Protective antigen |
FluMist
|
1562
|
KDELR2 |
Homo sapiens |
|
11014
|
|
154736713
|
tcag7.840 |
AACC02000122 |
NP_001094073 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
3713
|
KIAA0907 |
Homo sapiens |
|
22889
|
|
55741675
|
|
AL355388 |
NP_055764 |
|
|
KH domain containing 4, pre-mRNA splicing factor |
Protective antigen |
FluMist
|
3638
|
KLF6 |
Homo sapiens |
|
1316
|
|
236460555
|
|
AF284036 |
NP_001153596 |
|
|
transcript variant D |
Protective antigen |
FluMist
|
3757
|
KLHL14 |
Homo sapiens |
|
57565
|
|
55741643
|
|
AC012123 |
NP_065856 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3619
|
KLHL6 |
Homo sapiens |
|
89857
|
|
109150407
|
|
AC069211 |
NP_569713 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3654
|
KLRD1 |
Homo sapiens |
|
3824
|
|
1188456608
|
|
AB010084 |
NP_001107868 |
|
|
transcript variant X11 |
Protective antigen |
FluMist
|
3791
|
KLRD1 |
Homo sapiens |
|
3824
|
|
1188456608
|
|
AB010084 |
NP_001107868 |
|
|
transcript variant X11 |
Protective antigen |
Fluarix
|
3703
|
KLRG1 |
Homo sapiens |
|
10219
|
|
1041817916
|
|
AC006581 |
NP_001316028 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
1492
|
KRAS |
Homo sapiens |
|
3845
|
|
15718761
|
|
ABBA01068017 |
NP_004976 |
|
|
b |
Vaximmutor |
FluMist
|
3583
|
KRCC1 |
Homo sapiens |
|
51315
|
|
751868086
|
|
AC108479 |
NP_001291455 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3634
|
KRIT1 |
Homo sapiens |
|
889
|
|
61742817
|
|
AC000120 |
NP_001013424 |
|
|
transcript variant 9 |
Protective antigen |
FluMist
|
3218
|
LAIR1 |
Homo sapiens |
|
3903
|
|
612407867
|
XXbac-BCX403H19.4 |
ABBA01068164 |
NP_001275952 |
|
|
transcript variant g |
Vaximmutor |
APSV Wetvax
Fluarix
|
3792
|
LFNG |
Homo sapiens |
|
3955
|
|
93140999
|
|
AC092488 |
NP_001035257 |
|
|
transcript variant 3 |
Protective antigen |
Fluarix
|
2004
|
LGALS9 |
Homo sapiens |
|
3965
|
|
1054470958
|
|
AB040130 |
NP_001317092 |
|
|
transcript variant 1 |
Protective antigen |
YF-Vax
APSV Wetvax
RE
|
2042
|
LILRB1 |
Homo sapiens |
|
10859
|
|
612149791
|
XXbac-BCX85G21.4 |
ABBA01068150 |
NP_001075106 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
APSV Wetvax
FluMist
|
3772
|
LOC100130100 |
Homo sapiens |
|
100130100
|
|
|
|
|
|
|
|
Ig kappa chain V-I region Walker-like |
Protective antigen |
Fluarix
|
3738
|
LOC100131541 |
Homo sapiens |
|
100131541
|
|
|
|
AP000848 |
|
|
|
uncharacterized LOC100131541 |
Protective antigen |
FluMist
|
3739
|
LOC100131993 |
Homo sapiens |
|
100131993
|
|
|
|
AL157813 |
|
|
|
similar to hCG2020760 |
Protective antigen |
FluMist
|
3740
|
LOC100170939 |
Homo sapiens |
|
100170939
|
|
|
|
AC138866 |
|
|
|
glucuronidase, beta pseudogene |
Protective antigen |
FluMist
|
3773
|
LOC100287723 |
Homo sapiens |
|
100287723
|
|
|
|
|
|
|
|
Ig kappa chain V-I region Walker-like |
Protective antigen |
Fluarix
|
3741
|
LOC100288387 |
Homo sapiens |
|
100288387
|
|
|
|
|
|
|
|
similar to c-jun |
Protective antigen |
FluMist
|
3742
|
LOC100288939 |
Homo sapiens |
|
100288939
|
|
|
|
AC007382 |
|
|
|
hypothetical LOC100288939 |
Protective antigen |
FluMist
|
3781
|
LOC144571 |
Homo sapiens |
|
144571
|
|
|
|
AC007436 |
|
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3628
|
LOC150166 |
Homo sapiens |
|
150166
|
|
|
|
AC007436 |
|
|
|
hypothetical protein LOC150166 |
Protective antigen |
FluMist
|
3770
|
LOC284837 |
Homo sapiens |
|
284837
|
|
|
|
AP001053 |
|
|
|
apoptosis associated transcript in bladder cancer |
Protective antigen |
FluMist
Fluarix
|
3762
|
LOC91316 |
Homo sapiens |
|
91316
|
|
|
|
AP000346 |
|
|
|
glucuronidase, beta pseudogene 11 |
Protective antigen |
Fluarix
|
3763
|
LOC96610 |
Homo sapiens |
|
96610
|
|
|
|
AC245060 |
|
|
|
BMS1, ribosome biogenesis factor pseudogene 20 |
Protective antigen |
Fluarix
|
3242
|
LPXN |
Homo sapiens |
|
9404
|
|
221316659
|
|
ABBA01021488 |
NP_001137467 |
|
|
transcript variant X1 |
Vaximmutor |
APSV Wetvax
FluMist
|
3593
|
LRRC8D |
Homo sapiens |
|
55144
|
|
197333706
|
|
AC099568 |
NP_001127951 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3244
|
LYN |
Homo sapiens |
|
4067
|
|
162287326
|
|
ABBA01041754 |
NP_001104567 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
3786
|
LYST |
Homo sapiens |
|
1130
|
|
54292123
|
|
AL121997 |
NP_000072 |
|
|
transcript variant 3 |
Protective antigen |
Fluarix
|
3655
|
M6PR |
Homo sapiens |
|
4074
|
|
333440434
|
|
AC006581 |
NP_001193953 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3793
|
MAN1A1 |
Homo sapiens |
|
4121
|
|
24497519
|
|
AL022722 |
NP_005898 |
|
|
transcript variant X4 |
Protective antigen |
Fluarix
|
1539
|
MANF |
Homo sapiens |
|
7873
|
|
299523086
|
|
ABBA01024531 |
NP_006001 |
|
|
mesencephalic astrocyte-derived neurotrophic factor |
Vaximmutor |
Fluarix
YF-Vax
|
1575
|
MAP2K3 |
Homo sapiens |
|
5606
|
|
21618347
|
|
ABBA01050464 |
NP_002747 |
|
|
B |
Vaximmutor |
Fluarix
|
1509
|
MAP3K14 |
Homo sapiens |
|
9020
|
|
115298645
|
|
ABBA01028318 |
NP_003945 |
|
|
mitogen-activated protein kinase kinase kinase 14 |
Vaximmutor |
FluMist
|
1532
|
MAP3K5 |
Homo sapiens |
|
4217
|
|
5174547
|
RP3-325F22.4 |
ABBA01025825 |
NP_005914 |
|
|
mitogen-activated protein kinase kinase kinase 5 |
Vaximmutor |
FluMist
YF-Vax
|
1526
|
MAP3K7 |
Homo sapiens |
|
6885
|
|
4507361
|
RP1-154G14.1 |
ABBA01040553 |
NP_003179 |
|
|
D |
Vaximmutor |
FluMist
|
3694
|
MAP4K4 |
Homo sapiens |
|
9448
|
|
336020358
|
|
AC005035 |
NP_001229488 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
1479
|
MAPK1 |
Homo sapiens |
|
5594
|
|
66932916
|
|
ABBA01055067 |
NP_002736 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
Fluarix
|
1531
|
MAPK14 |
Homo sapiens |
|
1432
|
|
4503069
|
RP1-179N16.5 |
ABBA01038249 |
NP_001306 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
|
1487
|
MAPKAPK2 |
Homo sapiens |
|
9261
|
|
10863901
|
|
ABBA01010192 |
NP_004750 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
3589
|
MARCH1 |
|
|
|
|
|
|
|
|
|
|
|
|
FluMist
|
1467
|
MAVS |
Homo sapiens |
|
57506
|
|
330688443
|
|
ABBA01053835 |
NP_001193420 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
3656
|
MEF2C |
Homo sapiens |
|
4208
|
|
196114945
|
|
AC008525 |
NP_001124477 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3642
|
MEGF9 |
Homo sapiens |
|
1955
|
|
304434526
|
|
AL138836 |
NP_001073966 |
|
|
multiple EGF like domains 9 |
Protective antigen |
FluMist
|
3716
|
MESDC2 |
Homo sapiens |
|
23184
|
|
74136552
|
|
AC027808 |
NP_055969 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3605
|
METTL3 |
Homo sapiens |
|
56339
|
|
21361827
|
|
AE000658 |
NP_062826 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3721
|
METTL7A |
Homo sapiens |
|
25840
|
|
89145417
|
|
AC008121 |
NP_054752 |
|
|
methyltransferase like 7A |
Protective antigen |
FluMist
|
3729
|
MFSD8 |
Homo sapiens |
|
256471
|
|
1390435878
|
|
AC099340 |
NP_001350449 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3657
|
MGAT2 |
Homo sapiens |
|
4247
|
|
4505163
|
|
AL139099 |
NP_002399 |
|
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
Protective antigen |
FluMist
Fluarix
|
3658
|
MGST1 |
Homo sapiens |
|
4257
|
|
386869519
|
|
AC007528 |
NP_001247440 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3626
|
MITD1 |
Homo sapiens |
|
129531
|
|
1000232090
|
|
AC092587 |
NP_001307346 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3680
|
MKKS |
Homo sapiens |
|
8195
|
|
9055272
|
|
AL034430 |
NP_061336 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3659
|
MLLT3 |
Homo sapiens |
|
4300
|
|
557878595
|
|
AL163193 |
NP_001273620 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
1486
|
MNDA |
Homo sapiens |
|
4332
|
|
4505227
|
RP11-432E18.11-001 |
ABBA01016623 |
NP_002423 |
|
|
myeloid cell nuclear differentiation antigen |
Vaximmutor |
FluMist
Fluarix
APSV Wetvax
|
1555
|
MOGS |
Homo sapiens |
|
7841
|
|
225903430
|
|
ABBA01075601 |
NP_001139630 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
3714
|
MON2 |
Homo sapiens |
|
23041
|
|
510937035
|
|
AC026115 |
NP_001265398 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3722
|
MOSPD2 |
Homo sapiens |
|
158747
|
|
294489346
|
|
AC121340 |
NP_001170946 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3768
|
MOSPD2 |
Homo sapiens |
|
158747
|
|
294489346
|
|
AC121340 |
NP_001170946 |
|
|
transcript variant 3 |
Protective antigen |
Fluarix
|
2631
|
MPEG1 |
Homo sapiens |
|
219972
|
|
133505169
|
|
ABBA01021496 |
NP_001034485 |
|
|
macrophage expressed 1 |
Vaximmutor |
YF-Vax
FluMist
|
3705
|
MRPS31 |
Homo sapiens |
|
10240
|
|
186928854
|
|
AL161614 |
NP_005821 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3617
|
MS4A14 |
Homo sapiens |
|
84689
|
|
119226220
|
|
AP003127 |
NP_001073160 |
|
|
transcript variant 8 |
Protective antigen |
FluMist
|
3584
|
MS4A4A |
Homo sapiens |
|
51338
|
|
343098442
|
|
AP003127 |
NP_001230195 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3752
|
MS4A4A |
Homo sapiens |
|
51338
|
|
343098442
|
|
AP003127 |
NP_001230195 |
|
|
transcript variant 2 |
Protective antigen |
Fluarix
|
3258
|
MS4A6A |
Homo sapiens |
|
64231
|
|
351721142
|
|
ABBA01021510 |
NP_001234928 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
FluMist
|
2168
|
MS4A7 |
Homo sapiens |
|
58475
|
|
11139299
|
|
ABBA01021510 |
NP_067024 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
FluMist
Fluarix
|
1517
|
MSR1 |
Homo sapiens |
|
4481
|
|
4505259
|
|
ABBA01021596 |
NP_002436 |
|
|
SR-AIII |
Vaximmutor |
FluMist
|
3726
|
MTIF3 |
Homo sapiens |
|
219402
|
|
261878554
|
|
AL137059 |
NP_001159733 |
|
|
transcript variant X11 |
Protective antigen |
FluMist
|
1448
|
MX1 |
Homo sapiens |
|
4599
|
|
222136619
|
|
ABBA01044663 |
NP_001138397 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1449
|
MX2 |
Homo sapiens |
|
4600
|
|
11342664
|
|
ABBA01044663 |
NP_002454 |
|
|
myxovirus (influenza virus) resistance 2 (mouse) |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
RE
|
1807
|
MYD88 |
Homo sapiens |
|
4615
|
|
1478051048
|
|
AP006309 |
NP_001166037 |
|
|
transcript variant X2 |
Protective antigen |
YF-Vax
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
1980
|
MYOF |
Homo sapiens |
|
26509
|
|
7305053
|
RP11-624L12.2 |
ABBA01021868 |
NP_038479 |
|
|
transcript variant X2 |
Vaximmutor |
YF-Vax
FluMist
|
2119
|
NAGA |
Homo sapiens |
|
4668
|
|
4557781
|
|
ABBA01055661 |
NP_000253 |
|
|
transcript variant X2 |
Vaximmutor |
YF-Vax
FluMist
|
2027
|
NAGK |
Homo sapiens |
|
55577
|
|
295844834
|
|
ABBA01075547 |
NP_060037 |
|
|
transcript variant X1 |
Vaximmutor |
YF-Vax
FluMist
|
3660
|
NAIP |
Homo sapiens |
|
4671
|
|
1099511134
|
|
AB048533 |
NP_001333799 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3697
|
NCOR1 |
Homo sapiens |
|
9611
|
|
298919179
|
|
AC002553 |
NP_001177367 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3661
|
NDUFA8 |
Homo sapiens |
|
4702
|
|
970598260
|
|
AL162423 |
NP_001305124 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
Fluarix
|
2922
|
NEK7 |
Homo sapiens |
|
140609
|
|
19424132
|
|
ABBA01027579 |
NP_598001 |
|
|
NIMA-related kinase 7 |
Vaximmutor |
YF-Vax
FluMist
|
3662
|
NFATC3 |
Homo sapiens |
|
4775
|
|
4758804
|
|
AC020978 |
NP_004546 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
2816
|
NFKBIA |
Homo sapiens |
|
4792
|
|
10092619
|
|
ABBA01061503 |
NP_065390 |
|
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
Vaximmutor |
YF-Vax
2008–2009 trivalent influenza vaccine
|
1576
|
NOD2 |
Homo sapiens |
|
64127
|
|
11545912
|
|
ABBA01000867 |
NP_071445 |
|
|
nucleotide-binding oligomerization domain containing 2 |
Vaximmutor |
Fluarix
YF-Vax
|
3598
|
NSUN5 |
Homo sapiens |
|
55695
|
|
270288816
|
|
AC073841 |
NP_001161819 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3630
|
NSUN5P1 |
Homo sapiens |
|
155400
|
|
|
|
AC006014 |
|
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
2741
|
NSUN5P2 |
Homo sapiens |
|
260294
|
|
|
|
ABBA01186092 |
|
|
|
NOP2/Sun domain family, member 5 pseudogene 2 |
Vaximmutor |
FluMist
|
3687
|
NUMB |
Homo sapiens |
|
8650
|
|
54144625
|
|
AC004846 |
NP_001005743 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3717
|
NUP210 |
Homo sapiens |
|
23225
|
|
27477134
|
|
AC027124 |
NP_079199 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3730
|
NUP43 |
Homo sapiens |
|
348995
|
|
38605733
|
|
AJ334828 |
NP_942590 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
1450
|
OAS1 |
Homo sapiens |
|
4938
|
|
74229015
|
|
A14571 |
NP_001027581 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1451
|
OAS2 |
Homo sapiens |
|
4939
|
|
74229021
|
|
ABBA01019942 |
NP_001027903 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1452
|
OAS3 |
Homo sapiens |
|
4940
|
|
45007007
|
P/OKcl.4 |
ABBA01019941 |
NP_006178 |
|
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
Vaximmutor |
FluMist
YF-Vax
|
1784
|
OASL |
Homo sapiens |
|
8638
|
|
387849330
|
|
AC079602 |
NP_001248754 |
|
|
transcript variant X1 |
Protective antigen |
YF-Vax
2008–2009 trivalent influenza vaccine
|
3621
|
OSBPL11 |
Homo sapiens |
|
114885
|
|
19923592
|
|
AC016959 |
NP_073613 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1469
|
OSM |
Homo sapiens |
|
5008
|
|
10092621
|
|
ABBA01055293 |
NP_065391 |
|
|
oncostatin M |
Vaximmutor |
FluMist
|
3750
|
OSTM1 |
Homo sapiens |
|
28962
|
|
30025026
|
|
CH471051 |
NP_054747 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3663
|
PCMT1 |
Homo sapiens |
|
5110
|
|
354983493
|
|
AH006872 |
NP_001238978 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3796
|
PCMT1 |
Homo sapiens |
|
5110
|
|
354983493
|
|
AH006872 |
NP_001238978 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
1537
|
PDIA4 from humans |
Homo sapiens |
|
9601
|
|
4758304
|
|
AACC02000041 |
NP_004902 |
|
|
protein disulfide isomerase family A, member 4 |
Vaximmutor |
Fluarix
YF-Vax
|
1553
|
PDIA6 |
Homo sapiens |
|
10130
|
|
5031973
|
|
ABBA01015631 |
NP_005733 |
|
|
protein disulfide isomerase family A, member 6 |
Vaximmutor |
Fluarix
|
1545
|
PECAM1 |
Homo sapiens |
|
5175
|
|
313760624
|
|
ABBA01035302 |
NP_000433 |
|
|
platelet/endothelial cell adhesion molecule 1 |
Vaximmutor |
Fluarix
YF-Vax
|
3698
|
PHF14 |
Homo sapiens |
|
9678
|
|
55769548
|
|
AC005007 |
NP_055475 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3591
|
PID1 |
Homo sapiens |
|
55022
|
|
154816208
|
|
AC006368 |
NP_001094288 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
1563
|
PIGA |
Homo sapiens |
|
5277
|
|
11863130
|
|
ABBA01071290 |
NP_002632 |
|
|
transcript variant 3 |
Vaximmutor |
Fluarix
|
1472
|
PIK3C3 |
Homo sapiens |
|
5289
|
|
34761064
|
|
ABBA01022369 |
NP_002638 |
|
|
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
Vaximmutor |
FluMist
|
1493
|
PIK3CA |
Homo sapiens |
|
5290
|
|
54792082
|
|
ABBA01058543 |
NP_006209 |
|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
Vaximmutor |
FluMist
|
1508
|
PIK3CG |
Homo sapiens |
|
5294
|
|
21237725
|
|
AACC02000004 |
NP_002640 |
|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
Vaximmutor |
FluMist
|
3778
|
PION |
Homo sapiens |
|
54103
|
|
1186128445
|
|
AC004921 |
NP_001337825 |
|
|
transcript variant X8 |
Protective antigen |
FluMist
|
1453
|
PLSCR1 |
Homo sapiens |
|
5359
|
|
1394533327
|
|
AC069528 |
NP_001350801 |
|
|
transcript variant X7 |
Protective antigen |
FluMist
YF-Vax
APSV Wetvax
|
3312
|
PLXNB2 |
Homo sapiens |
|
23654
|
|
149363636
|
|
ABBA01011383 |
NP_036533 |
|
|
transcript variant X5 |
Vaximmutor |
APSV Wetvax
FluMist
|
3664
|
PMS1 |
Homo sapiens |
|
5378
|
|
4505911
|
|
AB006462 |
NP_000525 |
|
|
transcript variant 8 |
Protective antigen |
FluMist
|
3797
|
PMS2P2 |
Homo sapiens |
|
5380
|
|
|
|
AC004980 |
|
|
|
PMS1 homolog 2, mismatch repair system component pseudogene 2 |
Protective antigen |
Fluarix
|
3627
|
POC5 |
Homo sapiens |
|
134359
|
|
151101311
|
|
AC010245 |
NP_001092741 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3585
|
POLK |
Homo sapiens |
|
51426
|
|
1066546963
|
|
AB036934 |
NP_001332850 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3315
|
POLR3E |
Homo sapiens |
|
55718
|
|
384475535
|
|
ABBA01003840 |
NP_001244962 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
1540
|
POU2AF1 |
Homo sapiens |
|
5450
|
|
167900478
|
|
ABBA01039821 |
NP_006226 |
|
|
POU class 2 associating factor 1 |
Vaximmutor |
Fluarix
YF-Vax
|
1543
|
POU2F2 |
Homo sapiens |
|
5452
|
|
333360875
|
|
ABBA01040836 |
NP_001193954 |
|
|
transcript variant 4 |
Vaximmutor |
Fluarix
|
3761
|
PPAPDC1B |
Homo sapiens |
|
84513
|
|
156523237
|
|
AC087362 |
NP_001096029 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3553
|
PQBP1 |
Homo sapiens |
|
10084
|
|
74027247
|
|
AB041832 |
NP_001027553 |
|
|
transcript variant X3 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
2205
|
PRDX4 |
Homo sapiens |
|
10549
|
|
5453549
|
|
ABBA01072207 |
NP_006397 |
|
|
transcript variant X1 |
Vaximmutor |
YF-Vax
Fluarix
|
1815
|
PRF1 |
Homo sapiens |
|
5551
|
|
133908621
|
RP11-710A11.3 |
AL355344 |
NP_001076585 |
|
|
transcript variant 1 |
Protective antigen |
YF-Vax
Fluarix
|
1572
|
PRKACA |
Homo sapiens |
|
5566
|
|
4506055
|
|
ABBA01029689 |
NP_002721 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
|
1518
|
PRKCA from humans |
|
|
|
|
|
|
|
|
|
|
|
|
FluMist
|
1591
|
PSEN1 |
Homo sapiens |
|
5663
|
|
4506163
|
|
AB159776 |
NP_000012 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
APSV Wetvax
FluMist
|
3665
|
PTGDR |
Homo sapiens |
|
5729
|
|
28466969
|
|
AL365475 |
NP_000944 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1496
|
PTGS2 |
Homo sapiens |
|
5743
|
|
4506265
|
|
ABBA01027702 |
NP_000954 |
|
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
Vaximmutor |
FluMist
|
1581
|
PTPN6 |
Homo sapiens |
|
5777
|
|
18104989
|
|
AB079851 |
NP_002822 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
APSV Wetvax
|
3577
|
PYCARD |
Homo sapiens |
|
29108
|
|
10835256
|
|
AC009088 |
NP_037390 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3693
|
QKI |
Homo sapiens |
|
9444
|
|
666637982
|
|
AB067808 |
NP_001288014 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3708
|
RAB10 |
Homo sapiens |
|
10890
|
|
256222019
|
|
AC011742 |
NP_057215 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
2155
|
RAB8A |
Homo sapiens |
|
4218
|
|
16933567
|
|
ABBA01051130 |
NP_005361 |
|
|
RAB8A, member RAS oncogene family |
Vaximmutor |
YF-Vax
APSV Wetvax
Fluarix
|
3666
|
RALA |
Homo sapiens |
|
5898
|
|
33946329
|
|
AC004837 |
NP_005393 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3798
|
RAP2A |
Homo sapiens |
|
5911
|
|
10518344
|
|
A08695 |
NP_066361 |
|
|
RAP2A, member of RAS oncogene family |
Protective antigen |
Fluarix
|
3616
|
RASSF4 |
Homo sapiens |
|
83937
|
|
23510360
|
|
AL353801 |
NP_114412 |
|
|
transcript variant X12 |
Protective antigen |
FluMist
|
1488
|
REL |
Homo sapiens |
|
5966
|
|
4506473
|
|
ABBA01075339 |
NP_002899 |
|
|
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
Vaximmutor |
FluMist
|
3357
|
RIPK2 |
Homo sapiens |
|
8767
|
|
4506537
|
|
ABBA01037399 |
NP_003812 |
|
|
transcript variant X1 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
1920
|
RNASE2 |
Homo sapiens |
|
6036
|
|
4506549
|
|
ABBA01061237 |
NP_002925 |
|
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
Vaximmutor |
YF-Vax
FluMist
Fluarix
|
3358
|
RNASE6 |
Homo sapiens |
|
6039
|
|
5032045
|
|
ABBA01061235 |
NP_005606 |
|
|
ribonuclease, RNase A family, k6 |
Vaximmutor |
APSV Wetvax
FluMist
|
3613
|
RNF170 |
Homo sapiens |
|
81790
|
|
237858650
|
|
AC009634 |
NP_001153695 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
1871
|
RNF213 |
Homo sapiens |
|
57674
|
|
597709777
|
hCG_1812857 |
ABBA01015400 |
NP_001243000 |
|
|
transcript variant X1 |
Vaximmutor |
YF-Vax
FluMist
|
3696
|
ROCK2 |
Homo sapiens |
|
9475
|
|
1011750897
|
|
AC018463 |
NP_001308572 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
1549
|
RPN1 |
Homo sapiens |
|
6184
|
|
4506675
|
|
ABBA01020902 |
NP_002941 |
|
|
ribophorin I |
Vaximmutor |
Fluarix
|
1551
|
RPN2 |
Homo sapiens |
|
6185
|
|
209413738
|
RP3-343K2.2 |
ABBA01006615 |
NP_001129243 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
|
3374
|
RPS27 |
Homo sapiens |
|
6232
|
|
4506711
|
|
AB007162 |
NP_001021 |
|
|
ribosomal protein S27 |
Vaximmutor |
APSV Wetvax
Fluarix
|
2883
|
RRM2 |
Homo sapiens |
|
6241
|
|
4557845
|
|
ABBA01015604 |
NP_001025 |
|
|
transcript variant 1 |
Vaximmutor |
YF-Vax
Fluarix
|
3667
|
RTN1 |
Homo sapiens |
|
6252
|
|
1393428206
|
|
AL121694 |
NP_001350631 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3378
|
S100A4 |
Homo sapiens |
|
6275
|
|
4506765
|
|
ABBA01049435 |
NP_002952 |
|
|
transcript variant 2 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
3610
|
S100PBP |
Homo sapiens |
|
64766
|
|
371122113
|
|
AC114493 |
NP_001243050 |
|
|
transcript variant X5 |
Protective antigen |
FluMist
|
3629
|
SAMD3 |
Homo sapiens |
|
154075
|
|
126032305
|
|
AL121947 |
NP_001017373 |
|
|
transcript variant X4 |
Protective antigen |
FluMist
|
1854
|
SAMD9L |
Homo sapiens |
|
219285
|
|
51339291
|
|
ABBA01045794 |
NP_689916 |
|
|
transcript variant X5 |
Vaximmutor |
YF-Vax
FluMist
|
3571
|
SAMHD1 |
Homo sapiens |
|
25939
|
|
1392111272
|
|
AL079335 |
NP_001350658 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3688
|
SAP30 |
Homo sapiens |
|
8819
|
|
4506783
|
|
AC097534 |
NP_003855 |
|
|
Sin3A associated protein 30 |
Protective antigen |
FluMist
|
1560
|
SEC 11C |
Homo sapiens |
|
90701
|
|
15150809
|
|
ABBA01056162 |
NP_150596 |
|
|
SEC 11 homolog C (S. cerevisiae) |
Vaximmutor |
Fluarix
YF-Vax
|
1552
|
SEC 23B from humans |
|
|
10483
|
|
|
|
|
|
|
|
|
Vaximmutor |
Fluarix
|
1557
|
SEC 24D |
Homo sapiens |
|
9871
|
|
190343021
|
|
ABBA01044693 |
NP_055637 |
|
|
SEC 24 family, member D (S. cerevisiae) |
Vaximmutor |
Fluarix
|
2913
|
SEC 61A1 |
Homo sapiens |
|
29927
|
|
7019415
|
|
ABBA01020888 |
NP_037468 |
|
|
Sec61 alpha 1 subunit (S. cerevisiae) |
Vaximmutor |
YF-Vax
Fluarix
|
3615
|
SETDB2 |
Homo sapiens |
|
83852
|
|
238624099
|
|
AL136218 |
NP_001153780 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3715
|
SETX |
Homo sapiens |
|
23064
|
|
1191017961
|
|
AL159997 |
NP_001338456 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3782
|
SGK223 |
Homo sapiens |
|
157285
|
|
595582408
|
|
ABBA01026926 |
NP_001074295 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3723
|
SGMS2 |
Homo sapiens |
|
166929
|
|
210147407
|
|
AC096564 |
NP_001129729 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3765
|
SH2D1B |
Homo sapiens |
|
117157
|
|
54792745
|
|
AF020264 |
NP_444512 |
|
|
SH2 domain containing 1B |
Protective antigen |
Fluarix
|
1506
|
SIRPA |
Homo sapiens |
|
140885
|
|
91105764
|
RP4-684O24.2 |
ABBA01053783 |
NP_001035111 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
3620
|
SLAMF6 |
Homo sapiens |
|
114836
|
|
296040491
|
|
AL138930 |
NP_001171643 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3764
|
SLAMF6 |
Homo sapiens |
|
114836
|
|
296040491
|
|
AL138930 |
NP_001171643 |
|
|
transcript variant X3 |
Protective antigen |
Fluarix
|
3608
|
SLAMF7 |
Homo sapiens |
|
57823
|
|
543583691
|
|
AL121985 |
NP_001269517 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3758
|
SLAMF7 |
Homo sapiens |
|
57823
|
|
543583691
|
|
AL121985 |
NP_001269517 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
3604
|
SLC25A40 |
Homo sapiens |
|
55972
|
|
46094065
|
|
AC003083 |
NP_061331 |
|
|
solute carrier family 25 member 40 |
Protective antigen |
FluMist
|
3706
|
SLC35A1 |
Homo sapiens |
|
10559
|
|
270288773
|
|
AL049697 |
NP_001161870 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3579
|
SLC35B3 |
Homo sapiens |
|
51000
|
|
216547942
|
|
AL355815 |
NP_001136013 |
|
|
transcript variant X20 |
Protective antigen |
FluMist
|
1582
|
SLC7A7 |
Homo sapiens |
|
9056
|
|
186910306
|
|
AB031537 |
NP_001119577 |
|
|
transcript variant 3 |
Vaximmutor |
Fluarix
|
3540
|
SLFN11 |
Homo sapiens |
|
91607
|
|
157388957
|
|
AC060766 |
NP_001098057 |
|
|
transcript variant 4 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
1565
|
SMC3 |
Homo sapiens |
|
9126
|
|
4885399
|
|
ABBA01063026 |
NP_005436 |
|
|
structural maintenance of chromosomes 3 |
Vaximmutor |
Fluarix
|
3737
|
SNORA28 |
Homo sapiens |
|
677811
|
|
|
|
AL138976 |
|
|
|
small nucleolar RNA, H/ACA box 28 |
Protective antigen |
FluMist
Fluarix
|
3669
|
SNX1 |
Homo sapiens |
|
6642
|
|
339409190
|
|
AC021541 |
NP_001229862 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1436
|
SOCS3 |
Homo sapiens |
|
9021
|
|
45439352
|
|
ABBA01002927 |
NP_003946 |
|
|
suppressor of cytokine signaling 3 |
Vaximmutor |
FluMist
APSV Wetvax
|
3670
|
SON |
Homo sapiens |
|
6651
|
|
609876591
|
|
AP000303 |
NP_001278340 |
|
|
transcript variant c |
Protective antigen |
FluMist
|
3671
|
SOS1 |
Homo sapiens |
|
6654
|
|
15529996
|
|
AC019171 |
NP_005624 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
1554
|
SPCS2 |
Homo sapiens |
|
9789
|
|
162417971
|
|
ABBA01017476 |
NP_055567 |
|
|
signal peptidase complex subunit 2 homolog (S. cerevisiae) |
Vaximmutor |
Fluarix
|
3672
|
SPN |
Homo sapiens |
|
6693
|
|
71979937
|
|
AC009086 |
NP_001025459 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3427
|
SPTLC2 |
Homo sapiens |
|
9517
|
|
4758668
|
|
ABBA01030647 |
NP_004854 |
|
|
serine palmitoyltransferase, long chain base subunit 2 |
Vaximmutor |
APSV Wetvax
FluMist
Fluarix
|
3719
|
SRGAP2 |
Homo sapiens |
|
23380
|
|
282165721
|
|
AC244023 |
NP_001164108 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
1556
|
SRPR |
Homo sapiens |
|
6734
|
|
295424842
|
|
ABBA01031226 |
NP_001171313 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
|
1559
|
SSR1 |
Homo sapiens |
|
6745
|
|
169404009
|
PSEC 0262 |
ABBA01022040 |
NP_003135 |
|
|
signal sequence receptor, alpha |
Vaximmutor |
Fluarix
YF-Vax
|
3799
|
SSR3 |
Homo sapiens |
|
6747
|
|
815891066
|
|
AC092927 |
NP_001295126 |
|
|
transcript variant 2 |
Protective antigen |
Fluarix
|
3668
|
ST6GAL1 |
Homo sapiens |
|
6480
|
|
1222020091
|
|
AC007488 |
NP_001340845 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
1781
|
STAT1 |
Homo sapiens |
|
6772
|
|
6274552
|
|
AC067945 |
NP_009330 |
|
|
transcript variant X4 |
Protective antigen |
YF-Vax
2008–2009 trivalent influenza vaccine
|
1437
|
STAT2 |
Homo sapiens |
|
6773
|
|
4885615
|
|
ABBA01008423 |
NP_005410 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1568
|
STAT4 |
Homo sapiens |
|
6775
|
|
345110660
|
|
ABBA01062392 |
NP_001230764 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
2008–2009 trivalent influenza vaccine
|
1527
|
STAT6 |
Homo sapiens |
|
6778
|
|
296010864
|
|
ABBA01008450 |
NP_001171549 |
|
|
transcript variant 5 |
Vaximmutor |
FluMist
YF-Vax
|
3691
|
STK17B |
Homo sapiens |
|
9262
|
|
4758194
|
|
AC114760 |
NP_004217 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3712
|
STK38 |
Homo sapiens |
|
11329
|
|
760997938
|
|
CH471081 |
NP_001292031 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3790
|
STT3A |
Homo sapiens |
|
3703
|
|
511630715
|
|
AP001132 |
NP_001265432 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
3684
|
STX7 |
Homo sapiens |
|
8417
|
|
1031698849
|
|
AL357034 |
NP_001313507 |
|
|
transcript variant 2 |
Protective antigen |
FluMist
|
3776
|
SUV420H1 |
Homo sapiens |
|
51111
|
|
665505996
|
|
AP002992 |
NP_001287836 |
|
|
transcript variant X2 |
Protective antigen |
FluMist
|
3751
|
SUV420H1 |
Homo sapiens |
|
51111
|
|
665505996
|
|
AP002992 |
NP_001287836 |
|
|
transcript variant X2 |
Protective antigen |
Fluarix
|
3711
|
SYNRG |
Homo sapiens |
|
11276
|
|
254587988
|
|
AC004099 |
NP_001157016 |
|
|
transcript variant 5 |
Protective antigen |
FluMist
|
3445
|
TARP |
Homo sapiens |
|
445347
|
|
51702236
|
|
ABBA01056928 |
NP_001003799 |
|
|
transcript variant X1 |
Vaximmutor |
APSV Wetvax
FluMist
|
3710
|
TBC1D8 |
Homo sapiens |
|
11138
|
|
156231067
|
|
AC013722 |
NP_001095896 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1535
|
TCF7L2 |
Homo sapiens |
|
6934
|
|
226371764
|
RP11-357H24.1 |
ABBA01062997 |
NP_001139746 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
Fluarix
APSV Wetvax
|
3674
|
TFCP2 |
Homo sapiens |
|
7024
|
|
291219874
|
|
AC087884 |
NP_001166923 |
|
|
transcript variant 3 |
Protective antigen |
FluMist
|
3452
|
TFEC |
Homo sapiens |
|
22797
|
|
64762402
|
|
ABBA01057813 |
NP_001018068 |
|
|
transcript variant 2 |
Vaximmutor |
APSV Wetvax
FluMist
|
1489
|
TFRC |
Homo sapiens |
|
7037
|
|
189458819
|
|
ABBA01033706 |
NP_001121620 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
|
1507
|
TGFB1 |
Homo sapiens |
|
7040
|
|
63025222
|
|
ABBA01040804 |
NP_000651 |
|
|
transforming growth factor, beta 1 |
Vaximmutor |
FluMist
|
1514
|
TGFBR2 |
Homo sapiens |
|
7048
|
|
67782326
|
|
ABBA01024961 |
NP_001020018 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
|
3576
|
THYN1 |
Homo sapiens |
|
29087
|
|
83267859
|
|
AP000859 |
NP_001032381 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
3675
|
TIA1 |
Homo sapiens |
|
7072
|
|
1191017748
|
|
AC016700 |
NP_001338437 |
|
|
transcript variant 8 |
Protective antigen |
FluMist
|
1505
|
TICAM1 |
Homo sapiens |
|
148022
|
|
41281981
|
|
ABBA01056040 |
NP_891549 |
|
|
toll-like receptor adaptor molecule 1 |
Vaximmutor |
FluMist
YF-Vax
|
1443
|
TICAM2 |
Homo sapiens |
|
353376
|
|
33386674
|
|
ABBA01069032 |
NP_067681 |
|
|
toll-like receptor adaptor molecule 2 |
Vaximmutor |
FluMist
APSV Wetvax
|
1567
|
TLR5 from humans |
|
|
7100
|
|
|
|
|
|
|
|
|
Vaximmutor |
Fluarix
APSV Wetvax
FluMist
|
1113
|
TLR6 |
Homo sapiens |
|
10333
|
|
20143971
|
|
AC108044 |
NP_006059 |
|
|
toll-like receptor 6 |
Vaximmutor |
FluMist
|
1454
|
TLR7 |
Homo sapiens |
|
51284
|
|
7706093
|
UNQ248/PRO285 |
ABBA01071042 |
NP_057646 |
|
|
toll-like receptor 7 |
Vaximmutor |
FluMist
YF-Vax
2008–2009 trivalent influenza vaccine
|
1455
|
TLR8 |
Homo sapiens |
|
51311
|
|
20302168
|
UNQ249/PRO286 |
ABBA01071048 |
NP_619542 |
|
|
toll-like receptor 8 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
2008–2009 trivalent influenza vaccine
Fluarix
|
2530
|
TMEM63A |
Homo sapiens |
|
9725
|
|
270288733
|
RP4-559A3.1 |
ABBA01009662 |
NP_055513 |
|
|
transcript variant X1 |
Vaximmutor |
YF-Vax
FluMist
|
3581
|
TMEM69 |
Homo sapiens |
|
51249
|
|
118918409
|
|
AL604028 |
NP_057570 |
|
|
transcript variant X1 |
Protective antigen |
FluMist
|
1501
|
TNF |
Homo sapiens |
|
7124
|
|
25952111
|
DADB-70P7.1 |
AB088112 |
NP_000585 |
|
|
tumor necrosis factor |
Vaximmutor |
FluMist
|
1491
|
TNFAIP3 |
Homo sapiens |
|
7128
|
|
395393995
|
RP11-356I2.3 |
ABBA01025818 |
NP_001257436 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
APSV Wetvax
|
3760
|
TNFAIP8L2 |
Homo sapiens |
|
79626
|
|
157389001
|
|
AL592424 |
NP_078851 |
|
|
TNF alpha induced protein 8 like 2 |
Protective antigen |
Fluarix
|
1547
|
TNFRSF17 |
Homo sapiens |
|
608
|
|
23238192
|
|
AB052772 |
NP_001183 |
|
|
tumor necrosis factor receptor superfamily, member 17 |
Vaximmutor |
Fluarix
YF-Vax
2011–2012 trivalent inactivated vaccine (A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008).
|
1445
|
TNFSF10 |
Homo sapiens |
|
8743
|
|
300193032
|
|
ABBA01058648 |
NP_001177871 |
|
|
transcript variant 2 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1446
|
TNFSF13 |
Homo sapiens |
|
8741
|
|
310750385
|
UNQ383/PRO715 |
AB222992 |
NP_001185551 |
|
|
alpha |
Vaximmutor |
FluMist
Fluarix
APSV Wetvax
|
1447
|
TNFSF13B |
Homo sapiens |
|
10673
|
|
224548983
|
RP11-153I24.1 |
AB073225 |
NP_001139117 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
|
1802
|
TPD52 |
Homo sapiens |
|
7163
|
|
70608172
|
|
AC009686 |
NP_001020423 |
|
|
transcript variant 9 |
Protective antigen |
YF-Vax
APSV Wetvax
Fluarix
|
3474
|
TRAF3IP3 |
Homo sapiens |
|
80342
|
|
567757594
|
|
ABBA01048213 |
NP_001274683 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
FluMist
|
3805
|
TRAM2 |
Homo sapiens |
|
9697
|
|
6912450
|
|
AL049611 |
NP_036420 |
|
|
transcript variant X1 |
Protective antigen |
Fluarix
|
3673
|
TRGC2 |
Homo sapiens |
|
6967
|
|
|
|
AC006033 |
|
|
|
T cell receptor gamma constant 2 |
Protective antigen |
FluMist
|
3700
|
TRIM14 |
Homo sapiens |
|
9830
|
|
15208663
|
|
AL137073 |
NP_055603 |
|
|
transcript variant X3 |
Protective antigen |
FluMist
|
3767
|
TRIM69 |
Homo sapiens |
|
140691
|
|
667478158
|
|
AC018901 |
NP_001288073 |
|
|
transcript variant a |
Protective antigen |
Fluarix
|
3600
|
TTC17 |
Homo sapiens |
|
55761
|
|
808154180
|
|
AC023085 |
NP_001294872 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
1558
|
TXNDC5 |
Homo sapiens |
|
81567
|
|
224493972
|
RP1-126E20.1 |
ABBA01022048 |
NP_001139021 |
|
|
transcript variant 1 |
Vaximmutor |
Fluarix
YF-Vax
APSV Wetvax
|
1579
|
TYMP |
Homo sapiens |
|
1890
|
|
166158922
|
|
ABBA01042625 |
NP_001107227 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
YF-Vax
|
2180
|
TYMS |
Homo sapiens |
|
7298
|
|
4507751
|
OK/SW-cl.29 |
ABBA01049816 |
NP_001062 |
|
|
thymidylate synthetase |
Vaximmutor |
YF-Vax
Fluarix
|
1580
|
UBASH3B |
Homo sapiens |
|
84959
|
|
24497612
|
|
ABBA01031282 |
NP_116262 |
|
|
ubiquitin associated and SH3 domain containing B |
Vaximmutor |
Fluarix
|
3676
|
UBE2L3 |
Homo sapiens |
|
7332
|
|
373432684
|
|
AP000553 |
NP_001243284 |
|
|
transcript variant 4 |
Protective antigen |
FluMist
|
3728
|
UBN2 |
Homo sapiens |
|
254048
|
|
236459851
|
|
AC009220 |
NP_775840 |
|
|
transcript variant X4 |
Protective antigen |
FluMist
|
3686
|
USO1 |
Homo sapiens |
|
8615
|
|
586798211
|
|
AC104828 |
NP_001276978 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
3488
|
USP14 |
Homo sapiens |
|
9097
|
|
82880645
|
|
ABBA01049807 |
NP_001032411 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
2008–2009 trivalent influenza vaccine
|
3779
|
UTP6 |
Homo sapiens |
|
55813
|
|
49574529
|
|
AC004253 |
NP_060898 |
|
|
transcript variant X6 |
Protective antigen |
FluMist
|
3639
|
VCAN |
Homo sapiens |
|
1462
|
|
187607300
|
|
AC016568 |
NP_001119808 |
|
|
transcript variant 1 |
Protective antigen |
FluMist
|
2914
|
VPS35 |
Homo sapiens |
|
55737
|
|
17999541
|
TCCCTA00141 |
ABBA01013771 |
NP_060676 |
|
|
transcript variant X2 |
Vaximmutor |
YF-Vax
APSV Wetvax
FluMist
Fluarix
|
3498
|
VPS45 |
Homo sapiens |
|
11311
|
|
525342514
|
|
ABBA01049319 |
NP_001266282 |
|
|
transcript variant 1 |
Vaximmutor |
APSV Wetvax
FluMist
|
3499
|
VPS72 |
Homo sapiens |
|
6944
|
|
402793870
|
|
ABBA01049381 |
NP_001258016 |
|
|
transcript variant 3 |
Vaximmutor |
APSV Wetvax
FluMist
|
1442
|
XAF1 |
Homo sapiens |
|
54739
|
|
40288191
|
|
ABBA01054838 |
NP_059993 |
|
|
transcript variant 1 |
Vaximmutor |
FluMist
YF-Vax
APSV Wetvax
|
1593
|
XBP1 |
Homo sapiens |
|
7494
|
|
118640873
|
|
ABBA01055242 |
NP_001073007 |
|
|
transcript variant 2 |
Vaximmutor |
Fluarix
YF-Vax
2011–2012 trivalent inactivated vaccine (A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008).
|
3677
|
XPO1 |
Homo sapiens |
|
7514
|
|
4507943
|
|
AC016727 |
NP_003391 |
|
|
transcript variant X4 |
Protective antigen |
FluMist
|
1855
|
ZBP1 |
Homo sapiens |
|
81030
|
|
238550208
|
RP4-718J7.1 |
ABBA01052931 |
NP_001153889 |
|
|
transcript variant 3 |
Vaximmutor |
YF-Vax
RE
|
3679
|
ZFAND5 |
Homo sapiens |
|
7763
|
|
156231047
|
|
AF062072 |
NP_001095890 |
|
|
transcript variant c |
Protective antigen |
FluMist
|
3515
|
ZKSCAN1 |
Homo sapiens |
|
7586
|
|
559098463
|
|
ABBA01013241 |
NP_001273983 |
|
|
transcript variant 2 |
Vaximmutor |
APSV Wetvax
FluMist
Fluarix
|
3690
|
ZMYM6 |
Homo sapiens |
|
9204
|
|
115511046
|
|
AC114490 |
NP_009098 |
|
|
zinc finger MYM-type containing 6 |
Protective antigen |
FluMist
|
3552
|
ZNF112 |
Homo sapiens |
|
7771
|
|
138175847
|
|
AC084239 |
NP_001076804 |
|
|
transcript variant 4 |
Protective antigen |
2008–2009 trivalent influenza vaccine
|
3800
|
ZNF146 |
Homo sapiens |
|
7705
|
|
153791687
|
|
AC012617 |
NP_001093108 |
|
|
transcript variant 1 |
Protective antigen |
Fluarix
|
3678
|
ZNF207 |
Homo sapiens |
|
|